ACUTE VASCULAR TOXICITY AFTER COMBINATION CHEMOTHERAPY WITH CISPLATIN, VINBLASTINE, AND BLEOMYCIN FOR TESTICULAR CANCER

被引:67
|
作者
STEFENELLI, T
KUZMITS, R
ULRICH, W
GLOGAR, D
机构
[1] VIENNA UNIV,DEPT MED 2,A-1090 VIENNA,AUSTRIA
[2] VIENNA UNIV,DEPT PATHOL,A-1090 VIENNA,AUSTRIA
关键词
D O I
10.1093/oxfordjournals.eurheartj.a062542
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:552 / 556
页数:5
相关论文
共 50 条
  • [21] EARLY RESECTION OF RESIDUAL TUMOR DRIN CISPLATIN, VINBLASTINE, BLEOMYCIN COMBINATION CHEMOTHERAPY IN STATE-III AND BULKY STAGE-II NONSEMINOMATOUS TESTICULAR CANCER
    PIZZOCARO, G
    SALVIONI, R
    PASI, M
    ZANONI, F
    MILANI, A
    PILOTTI, S
    MONFARDINI, S
    CANCER, 1985, 56 (02) : 249 - 255
  • [22] DETECTION OF CARDIAC-ARRHYTHMIAS AND ISCHEMIC EVENTS IN COMBINATION CHEMOTHERAPY WITH CISPLATIN, ETOPOSIDE AND BLEOMYCIN FOR TESTICULAR CANCER
    COMAZZI, R
    MISRACHI, D
    GALIMBERTI, M
    PIVA, L
    PIZZOCCARO, G
    VILLANI, F
    ANTICANCER RESEARCH, 1989, 9 (03) : 663 - 665
  • [23] RETINAL TOXICITY AFTER CISPLATIN-BASED CHEMOTHERAPY IN PATIENTS WITH TESTICULAR CANCER
    Gild, Philipp
    Vetterlein, Malte W.
    Dieckmann, Klaus-Peter
    Matthies, Cord
    Wagner, Walter
    Ludwig, Tim A.
    Meyer, Christian P.
    Soave, Armin
    Dulz, Simon
    Asselborn, Niels H.
    Oechsle, Karin
    Bokemeyer, Carsten
    Becker, Andreas
    Fisch, Margit
    Hartmann, Michael
    Chun, Felix K. H.
    Kluth, Luis A.
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1085 - E1085
  • [24] COMBINATION CISPLATIN, VINBLASTINE, AND BLEOMYCIN CHEMOTHERAPY (PVB) FOR MALIGNANT GERM-CELL TUMORS OF THE OVARY
    CARLSON, RW
    SIKIC, BI
    TURBOW, MM
    BALLON, SC
    JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (10) : 645 - 651
  • [25] VASCULAR TOXICITY AND THE MECHANISM UNDERLYING RAYNAUDS-PHENOMENON IN PATIENTS TREATED WITH CISPLATIN, VINBLASTINE AND BLEOMYCIN
    HANSEN, SW
    OLSEN, N
    ROSSING, N
    RORTH, M
    ANNALS OF ONCOLOGY, 1990, 1 (04) : 289 - 292
  • [26] SEQUENTIAL COMBINATION CHEMOTHERAPY WITH VINBLASTINE-BLEOMYCIN AND DOXORUBICIN-CIS-DICHLORODIAMMINEPLATINUM(II) IN DISSEMINATED NONSEMINOMATOUS TESTICULAR CANCER
    SCHEULEN, ME
    SEEBER, S
    SCHILCHER, RB
    MEIER, CR
    SCHMIDT, CG
    CANCER TREATMENT REPORTS, 1980, 64 (4-5): : 599 - 609
  • [27] VASCULAR TOXICITY ASSOCIATED WITH CHEMOTHERAPY FOR TESTICULAR CANCER
    GERL, A
    ANTI-CANCER DRUGS, 1994, 5 (06) : 607 - 614
  • [28] COMBINATION CHEMOTHERAPY WITH CISPLATIN AND BLEOMYCIN IN ADVANCED CERVICAL-CANCER
    BLOCH, B
    NEL, CP
    KRIEL, A
    ATAD, J
    GOLDBERG, G
    CANCER TREATMENT REPORTS, 1984, 68 (06): : 891 - 893
  • [29] COMBINATION BLEOMYCIN, IFOSFAMIDE, AND CISPLATIN CHEMOTHERAPY IN CERVICAL-CANCER
    BUXTON, EJ
    MEANWELL, CA
    HILTON, C
    MOULD, JJ
    SPOONER, D
    CHETIYAWARDANA, A
    LATIEF, T
    PATERSON, M
    REDMAN, CW
    LUESLEY, DM
    BLACKLEDGE, GR
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (05) : 359 - 361
  • [30] COMBINATION CHEMOTHERAPY IN CANCER OF THE CERVIX WITH BLEOMYCIN, MITOMYCIN, CISPLATIN AND ETOPOSIDE
    CHAUVERGNE, J
    HERON, JF
    MAYER, F
    CHARROTCHINET, P
    TOULOUSE, C
    BULLETIN DU CANCER, 1993, 80 (01) : 70 - 79